Ectopic pregnancy and medical abortion

Obstetrics and Gynecology

Volumn 104, Issue 1, 2004, Pages 161-167

  Shannon, Caitlin ^a   Brothers, L Perry ^a   Philip, Neena M ^a   Winikoff, Beverly ^a  

^a GYNUITY HEALTH PROJECTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMEPROST; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; ECTOPIC PREGNANCY; FIRST TRIMESTER PREGNANCY; HUMAN; INDUCED ABORTION; MEDLINE; PREGNANCY TERMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCREENING; THERAPEUTIC ABORTION; FEMALE; PREGNANCY;

ABORTION, INDUCED; FEMALE; HUMANS; PREGNANCY; PREGNANCY, ECTOPIC; RANDOMIZED CONTROLLED TRIALS;

EID: 3242676060     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000130839.61098.12     Document Type: Review

References (66)

1. Ectopic pregnancy-United States, 1990-1992. MMWR Morb Mortal Wkly Rep 1995;44:46-8.
2. Saralya M, Berg CJ, Shulman H, Green CA, Atrash HK. Estimates of the annual number of clinically recognized pregnancies in the United States, 1981-1991. Am J Epidemiol 2000;152:287-9.
3. Tay JI, Moore J, Walker JJ. Ectopic pregnancy. BMJ 2000;320:916-9.
4. Coste J, Bouyer J, Germain E, Ughetto S, Pouly J, Job-Spira N. Recent declining trend in ectopic pregnancy in France: evidence of two clinicoepidemiologic entities. Fertil Steril 2000;74:881-6.
5. Job-Spira N, Fernandez H, Bouyer J, Pouly J, Germain E, Coste J. Ruptured tubal ectopic pregnancy: risk factors and reproductive outcome. Am J Obstet Gynecol 1999; 180:938-44.
6. Mäkinen J. Current treatment of ectopic pregnancy. Ann Med 1999;31:197-201.
7. Hausknecht R. Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. Contraception 2003;67:463-5.
8. Ashok PW, Templeton A, Wagaarachchi, Flett GMM. Factors affecting the outcome of early medical abortion: a review of 4,132 consecutive cases. BJOG 2002;109: 1281-9.
9. Ashok PW, Penney GC, Flett GMM, Templeton A. An effective regimen for early medical abortion: a report of 2,000 consecutive cases. Hum Reprod 1998;13:2962-5.
10. Aubeny E, Chatellier G. A randomized comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion. Eur J Contracept Reprod Health Care 2000;5:171-6.
11. Aubeny E. Efficacy and tolerance of mifepristone in a single dose of 600 mg in combination with misoprostol as an alternative to vacuum aspiration for the termination of pregnancies of less than or equal to 49 days of amenorrhea (1991). In: Mifepristone investigator's brochure. Paris, France: Exelgyn Laboratories; 1999.
12. Aubeny E, Peyron R, Turpin CL, Renault M, Targosz V, Silvestre L, et al. Termination of early pregnancy (up to and after 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [published erratum appears in Int J Fertil Menopausal Stud 1996;41:56]. Int J Fertil Menopausal Stud 1995;40(suppl):85-91.
13. Aubeny E, Peyron R, Turpin CL, Renault M, Targosz V, Silvestre L, et al. Termination of early pregnancy (up to and after 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [published erratum appears in Int J Fertil Menopausal Stud 1996;41:56]. Int J Fertil Menopausal Stud 1995;40(suppl):85-91.
14. Bardey J, Brown A, Elton R, Baird DT. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation. Hum Reprod 2001;16:2098-102.
15. Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3,161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000;62: 297-303.
16. Bjorge L, Johnsen SL, Midboe G, Augestad G, Okland I, Heiland H, et al. Early pregnancy termination with mifepristone and misoprostol in Norway. Acta Obstet Gynecol Scand 2001;80:1056-61.
17. Borgatta L, Burnhill MS, Tyson J, Leonhardt KK, Hausknecht RU, Haskell S. Early medical abortion with methotrexate and misoprostol. Obstet Gynecol 2001;97: 11-6.
18. Bugalho A, Mocumbi S, Faundes A, David E. Termination of pregnancies of less than six weeks gestation with a single dose of 800 micrograms of vaginal misoprostol. Contraception 2000;61:47-50.
19. Bugalho A, Faundes A, Jamisse L, Usfa M, Maria E, Bique C. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception 1996;53: 244-6.
20. Carbonell JL, Rodriguez J, Aragon S, Velazco A, Tanda R, Sanchez C, et al. Vaginal misoprostol 1,000 μg for early abortion. Contraception 2001;63:131-6.
21. Carbonell JL, Varela L, Velazco A, Cabezas E, Fernandez C, Sanchez C. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1998;57:83-8.
22. Carbonell JL, Varela L, Velazco A, Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception 1997;55:165-8.
23. Esteve JL, Varela L, Velazco A, Tanda R, Cabezas E, Sanchez C. Early abortion with 800 micrograms of misoprostol by the vaginal route. Contraception 1999;59: 219-25.
24. Carbonell I, Esteve JL, Velazco A, Varela L, Cabezas E, Fernandez C, et al. Misoprostol 3, 4, or 5 days after methotrexate for early abortion: a randomized trial. Contraception 1997;56:169-74.
25. Child TJ, Thomas J, Rees M, MacKenzie IZ. A comparative study of surgical and medical procedures: 932 pregnancy terminations up to 63 days gestation. Hum Reprod 2001;16:67-71.
26. Coyaji K, Elul B, Krishna U, Otiv S, Ambardekar S, Bopardikar A, et al. Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India. Contraception 2002;66:33-40.
27. Creinin MD, Potter C, Holovanisin M, Janczukiewicz L, Pymar HC, Schwartz JL, et al. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion. Am J Obstet Gynecol 2003;188:664-9.
28. Creinin MD, Carbonell J, Schwartz J, Varela L, Tanda R. A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion. Contraception 1999;59:11-6.
29. Creinin MD, Vittinghoff E, Schaff E, Klaisle C, Darney PD, Dean C. Medical abortion with oral methotrexate and vaginal misoprostol. Obstet Gynecol 1997;90:611-6.
30. Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G. Methotrexate and misoprostol for early abortion: a multicentre trial. I. Safety and efficacy. Contraception 1996;53: 321-7.
31. el-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332: 983-7.
32. Elul B, Hajri S, Ngoc NN, Ellertson C, Slama CB, Pearlman E, et al. Can women in less-developed countries use a simplified medical abortion regimen? Lancet 2001;357: 1402-5.
33. Gouk EV, Lincoln K, Khair A, Haslock J, Knight J, Gruickshank DJ. Medical termination of pregnancy at 63 to 83 days gestation. Br J Obstet Gynaecol 1999;106: 535-9.
34. Sang GW, Weng LJ, Shao QX, Du MK, Wu XZ, Lu YL, et al. Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05: a multicentre randomized clinical trial in China. Contraception 1994;50:501-10.
35. Hamoda H, Ashok PW, Flett GMM, Templeton A. Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases. Am J Obstet Gynecol 2003;188:1315-9.
36. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 1995;333:537-40.
37. A multicentre randomized comparative clinical trial of 200 mg RU 486 (mifepristone) single dose followed by either 5 mg 9-methylene PGE2 gel (meteneprost) or 600 mcg oral PGE1 (misoprostol) for termination of early pregnancy within 28 days of missed menstrual period. Indian Council of Medical Research Task Force Study. Contraception 2000;62:125-30.
38. Jain JK, Harwood B, Meckstroth KR, Mishell DR. Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxis. Contraception 2001;63:217-21.
39. Jain JK, Meckstroth KR, Mishell DR. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tables: historical comparison with mifepristone and oral misoprostol. Am J Obstet Gynecol 1999;181:1386-91.
40. Knudsen UB. First trimester abortion with mifepristone and vaginal misoprostol. Contraception 2001;63:247-50.
41. McKinley C, Thong KJ, Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 1993;8:1502-5.
42. Ngoc NTN, Winikoff B, Clark S, Ellertson C, Am KN, Hieu DT, et al. Safety, efficacy, and acceptability of mifepristone medical abortion in Vietnam. Int Fam Plann Perspect 1999;25:10-4,33.
43. Penney GC, McKessock L, Rispin R, El-Refaey H, Templeton AA. An effective, low cost regimen for early medical abortion. Br J Fam Plann 1995;21:5-6.
44. Peyron R, Aubeny E, Targosz V, Silvestre L, Renault M, Elkik F, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993;328:1509-13.
45. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. Contraception 2002;66:247-50.
46. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception 2001;64: 81-5.
47. Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000; 61:41-6.
48. Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion [published erratum appears in JAMA 2000;284:2597]. JAMA 2000;284:1948-53.
49. Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion [published erratum appears in JAMA 2000;284:2597]. JAMA 2000;284:1948-53.
50. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999;59:1-6.
51. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU 486) for abortion. J Fam Pract 1997;44:353-60.
52. Silvestre L, Dubois C, Renault M, Rezvani Y, Baulieu EE, Ulmann A. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue: a large scale French experience. N Engl J Med 1990;322: 645-8.
53. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:1241-7.
54. Tang OS, Lee SWH, Ho PC. A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone. Hum Reprod 2002; 17:2865-8.
55. Tang OS, Xu J, Cheng L, Lee SWH, Ho PC. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation. Hum Reprod 2002;17:1738-40.
56. Tang OS, Xu J, Cheng L, Lee SWH, Ho PC. The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: a randomized placebo controlled trial. Hum Reprod 2002;17:99-102.
57. Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion: an open multicentre study. UK Muldcentre Study Group. Contraception 1997;56: 361-6.
58. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation. UK Multicentre Study Group - final results. Contraception 1997;55:1-5.
59. Wiebe ER. Abortion induced with methotrexate and misoprostol: a comparison of various protocols. Contraception 1997;55:159-63.
60. Winikoff B, Sivin I, Coyaji KJ, Cabezas E, Bilian X, Sujuan G, et al. The acceptability of medical abortion in China, Cuba, and India. Int Fam Plann Perspect 1997;23:73-8, 89.
61. Lowering the doses of mifepristone and gemeprost for early abortion: a randomized controlled trial. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. BJOG 2001;108:738-42.
62. Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost: a randomized controlled trial. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. Acta Obstet Gynecol Scand 2001;80:447-51.
63. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomized trial. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. BJOG 2000; 107:524-30.
64. Termination of pregnancy with reduced doses of mifepristone. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. BMJ 1993; 307:532-7.
65. Pregnancy termination with mifepristone and gemeprost: a multicenter comparison between repeated doses and a single dose of mifepristone. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. Fertil Steril 1991;56:32-40.
66. Zikopoulos KA, Papanikolaou EG, Kalantaridou SN, Tsanadis GD, Plachouras NI, Dalkalitsis NA, et al. Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. Hum Reprod 2002;17:3079-83.